Chonluten 20mg - Advanced Respiratory Bioregulator
 
Chonluten is a cutting-edge tripeptide bioregulator that demonstrates remarkable specificity for lung tissue, offering powerful gene expression modulation capabilities. This synthetic peptide, also known as T-34 or EDG tripeptide, has shown exceptional potential in regulating inflammatory pathways, antioxidant defenses, and cellular repair mechanisms primarily within respiratory tissues.
 
What is Chonluten?
 
Chonluten represents a breakthrough in peptide bioregulation science, consisting of a precisely engineered three-amino-acid sequence (Glutamic acid-Aspartic acid-Glycine). Research indicates this peptide exhibits organ-specific activity, with its highest concentration of effects observed in lung tissues, while maintaining secondary activity in the gastrointestinal tract.
The peptide's unique mechanism involves direct interaction with cellular DNA, enabling it to regulate gene expression patterns associated with inflammation control, antioxidant enzyme production, and tissue repair processes.
Molecular Specifications
Molecular Formula: C₁₁H₁₇N₃O₈
Molecular Weight: 319.27 g/mol
CAS Number: 75007-24-8
Sequence: Glu-Asp-Gly
Alternative Names: T-34 tripeptide, EDG peptide
Bioregulation Mechanisms
Chonluten's small molecular size enables penetration through cellular and nuclear membranes, allowing direct interaction with genomic regulatory regions. Scientific investigations suggest the peptide can bind to DNA promoter sequences and influence epigenetic markers such as DNA methylation patterns.
Key regulatory targets include:
c-Fos gene regulation: Controls cellular proliferation and differentiation responses
Heat shock protein (HSP70): Enhances cellular stress resistance
Superoxide dismutase (SOD): Strengthens antioxidant defense systems
COX-2 and TNF-α modulation: Manages inflammatory cascade responses
 
Respiratory System Applications
 
Bronchial Mucosa Optimization
 
Chonluten demonstrates exceptional ability to normalize bronchial mucosa function by regulating the cellular barrier between respiratory pathways and circulatory systems. This optimization supports improved mucus production balance and enhanced structural integrity of the extracellular matrix.
Inflammatory Response Management
 
Research indicates Chonluten may effectively modulate STAT signaling pathways, particularly promoting STAT1 phosphorylation while potentially reducing STAT3 activity. This dual mechanism supports balanced immune responses and may help manage conditions involving chronic respiratory inflammation.
 
Cellular Repair Enhancement
 
The peptide's influence on proliferative gene expression supports accelerated tissue repair processes, making it particularly relevant for respiratory recovery applications.
 
Additional Research Applications
 
Gastrointestinal Support
 
While primarily targeting respiratory tissues, Chonluten exhibits secondary activity in gastrointestinal epithelial systems, where it may support mucosal integrity and inflammatory balance.
 
Antioxidant System Enhancement
 
Studies suggest Chonluten upregulates antioxidant enzyme expression, potentially offering protective effects against oxidative stress-related tissue damage.
 
Stress Response Optimization
 
The peptide's regulation of heat shock proteins and cellular stress response pathways indicates potential applications in maintaining cellular resilience under challenging environmental conditions.
 
Research Summary
 
Chonluten represents a sophisticated approach to respiratory system optimization through targeted gene expression modulation. Its unique ability to penetrate cellular barriers and directly influence DNA regulatory mechanisms sets it apart from conventional approaches to respiratory health support.
The peptide's documented effects on inflammatory gene regulation, antioxidant enzyme expression, and cellular repair mechanisms make it a valuable tool for research into respiratory physiology and tissue optimization strategies.
 
Important Research Considerations:
Chonluten exhibits exceptional bioavailability through subcutaneous administration
No significant adverse effects documented in research applications
Effects appear most pronounced with consistent research protocols
Individual research outcomes may vary based on specific study parameters
RESEARCH USE ONLY: This product is intended exclusively for laboratory research and scientific investigation. Not approved for human consumption or therapeutic use. Researchers must comply with all applicable regulations and safety protocols.